Nanobiotix S.A. (NANO.PA)

EUR 3.05

(2.35%)

Gross Profit Summary of Nanobiotix S.A.

  • Nanobiotix S.A.'s latest annual gross profit in 2023 was 36.2 Million EUR , up 1005.25% from previous year.
  • Nanobiotix S.A.'s latest quarterly gross profit in 2024 Q2 was 9.28 Million EUR , down 0.0% from previous quarter.
  • Nanobiotix S.A. reported a annual gross profit of 3.27 Million EUR in annual gross profit 2022, up 23.76% from previous year.
  • Nanobiotix S.A. reported a annual gross profit of 2.64 Million EUR in annual gross profit 2021, up 13.85% from previous year.
  • Nanobiotix S.A. reported a quarterly gross profit of 36.2 Million EUR for 2023 FY, up 1005.25% from previous quarter.
  • Nanobiotix S.A. reported a quarterly gross profit of 35.77 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Gross Profit Chart of Nanobiotix S.A. (2023 - 2011)

Historical Annual Gross Profit of Nanobiotix S.A. (2023 - 2011)

Year Gross Profit Gross Profit Growth
2023 36.2 Million EUR 1005.25%
2022 3.27 Million EUR 23.76%
2021 2.64 Million EUR 13.85%
2020 2.32 Million EUR -8.5%
2019 2.54 Million EUR -26.96%
2018 3.47 Million EUR 3.04%
2017 3.37 Million EUR -32.27%
2016 4.98 Million EUR 36.37%
2015 3.65 Million EUR 31.93%
2014 2.77 Million EUR 1398.23%
2013 184.93 Thousand EUR 149.4%
2012 74.15 Thousand EUR -94.55%
2011 1.36 Million EUR 0.0%

Peer Gross Profit Comparison of Nanobiotix S.A.

Name Gross Profit Gross Profit Difference
ABIONYX Pharma SA 618 Thousand EUR -5758.9%
ABIVAX Société Anonyme 3.91 Million EUR -825.089%
Adocia SA 1.38 Million EUR -2514.296%
Aelis Farma SA 12.35 Million EUR -192.992%
Biophytis S.A. -803 Thousand EUR 4609.091%
Advicenne S.A. 1.42 Million EUR -2439.13%
genOway Société anonyme 20.1 Million EUR -80.136%
IntegraGen SA 5.01 Million EUR -621.522%
Medesis Pharma S.A. -2.66 Million EUR 1458.767%
Neovacs S.A. 29.31 Thousand EUR -123417.773%
NFL Biosciences SA -56.06 Thousand EUR 64683.333%
Plant Advanced Technologies SA 2.15 Million EUR -1581.811%
Quantum Genomics Société Anonyme -1.41 Million EUR 2651.137%
Sensorion SA 3.78 Million EUR -855.895%
Theranexus Société Anonyme -4.63 Million EUR 880.565%
TME Pharma N.V. -127 Thousand EUR 28610.236%
Valbiotis SA 2.66 Million EUR -1257.121%
TheraVet SA -530.79 Thousand EUR 6921.453%
Valerio Therapeutics Société anonyme 1.26 Million EUR -2757.774%
DBV Technologies S.A. 4.15 Million EUR -770.47%
Genfit S.A. 28.22 Million EUR -28.288%
GeNeuro SA -293.8 Thousand EUR 12424.03%
Innate Pharma S.A. -4.12 Million EUR 978.622%
Inventiva S.A. 17.5 Million EUR -106.903%
MaaT Pharma SA 1.65 Million EUR -2087.795%
MedinCell S.A. 9.28 Million EUR -289.836%
OSE Immunotherapeutics SA 2.22 Million EUR -1525.864%
Poxel S.A. 1000.00 EUR -3620700.0%
GenSight Biologics S.A. 3 Million EUR -1106.933%
Transgene SA -28.4 Million EUR 227.475%
Valneva SE 52.83 Million EUR 31.472%